Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Assessment of changes in visits and antibiotic prescribing during the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic.

Keller SC, Caballero TM, Tamma PD, et al. Assessment of changes in visits and antibiotic prescribing during the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic. JAMA Netw Open. 2022;5(7):e2220512. doi:10.1001/jamanetworkopen.2022.20512.

Save
Print
July 20, 2022
Keller SC, Caballero TM, Tamma PD, et al. JAMA Netw Open. 2022;5(7):e2220512.
View more articles from the same authors.

Prescribing antibiotics increases the risk of resistant infections and can lead to patient harm. From December 2019 to November 2020, 389 ambulatory practices participated in a quality improvement project using the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use Program. The goal of the intervention was to support implementation and sustainment of antibiotic stewardship into practice culture, communication, and decision-making. Practices that completed the program and submitted data showed a significant decrease of antibiotic prescribing for acute respiratory infections at program completion in November 2020.

Save
Print
Cite
Citation

Keller SC, Caballero TM, Tamma PD, et al. Assessment of changes in visits and antibiotic prescribing during the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic. JAMA Netw Open. 2022;5(7):e2220512. doi:10.1001/jamanetworkopen.2022.20512.